Adiponectin and risk of new-onset diabetes mellitus after kidney transplantation

被引:36
作者
Bayés, B
Lauzurica, R
Granada, ML
Serra, A
Bonet, L
Fontseré, N
Salinas, I
Romero, R
机构
[1] Autonomous Univ Barcelona, Hosp Univ Germans Trias & Pujol, Dept Nephrol, Barcelona, Spain
[2] Autonomous Univ Barcelona, Hosp Univ Germans Trias & Pujol, Dept Clin Biochem, Barcelona, Spain
[3] Autonomous Univ Barcelona, Hosp Univ Germans Trias & Pujol, Dept Endocrinol, Barcelona, Spain
关键词
adiponectin; HOMA-IR index; leptin; diabetes mellitus; kidney transplantation;
D O I
10.1097/01.TP.0000132561.48217.B1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. New-onset diabetes mellitus after transplantation (NODAT) is a severe complication of kidney transplantation (KTx) with negative effects upon patient and graft survival. Several risk factors for NODAT have been described; however, the search for an early predictive marker is ongoing. It has recently been demonstrated that high concentrations of adiponectin (APN), which is an adipocyte-derived peptide with antiinflammatory and insulin-sensitizing properties, protect against future development of type 2 diabetes in healthy individuals. The purpose of this report was to study pretransplant insulin resistance and analyze pretransplant serum leptin and APN levels as independent risk factors for the development of NODAT. Methods. A total of 68 KTx patients were,studied [mean age, 48 +/- 11 years; 70% males; body mass index (BMI), 25 +/- 3 kg/m(2)]; 31 KTx patients with NODAT and 37 KTx patients without NODAT (non-NODAT) with similar age, sex, BMI, immunosuppression, and posttransplant time were studied. All patients received prednisone and calcineurin inhibitors (75% tacrolimus and 25% cyclosporine A), and 76% of patients received mycophenolate mofetil. Family history of diabetes mellitus was recorded. Pretransplant homeostasis model assessment for insulin resistance (HOMA-IR) index was calculated from fasting plasma glucose and insulin. Pretransplant serum leptin and APN levels were determined by radioimmunoassay. Results. NODAT patients showed higher pretransplant plasma insulin concentrations [NODAT, 13.4 (11-22.7) muIU/ mL; non-NODAT, 10.05 (7.45-18.4) muIU/mL; P = 0.049], HOMA-IR index [NODAT, 4.18 (2.49-5.75); non-NODAT, 2.63 (1.52-4.68); P = 0.043], and lower pretransplant serum APN concentration [NODAT, 8.78 (7.2-11.38) mug/mL; non-NODAT, 11.4 (8.56-15.27) mug/mL, P = 0.012]. Inverse correlations between APN and BMI (r = -0.33; P = 0.014) and APN and HOMA-IR index (r = -0.39; P = 0.002) and between APN and NODAT (r = -0.31; P = 0.011) were observed. Multiple logistic regression analysis showed the patients with lower pretransplant APN concentrations to be those at greater risk of developing NODAT [Odds Ratio = 0.832 (0.71-0.96); P = 0.01]. Conclusion. Pretransplant serum APN concentration is an independent predictive factor for NODAT development in kidney-transplanted patients.
引用
收藏
页码:26 / 30
页数:5
相关论文
共 24 条
[1]   Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity [J].
Arita, Y ;
Kihara, S ;
Ouchi, N ;
Takahashi, M ;
Maeda, K ;
Miyagawa, J ;
Hotta, K ;
Shimomura, I ;
Nakamura, T ;
Miyaoka, K ;
Kuriyama, H ;
Nishida, M ;
Yamashita, S ;
Okubo, K ;
Matsubara, K ;
Muraguchi, M ;
Ohmoto, Y ;
Funahashi, T ;
Matsuzawa, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (01) :79-83
[2]   Adiponectin in youth -: relationship to visceral adiposity, insulin sensitivity, and β-cell function [J].
Bacha, F ;
Saad, R ;
Gungor, N ;
Arslanian, SA .
DIABETES CARE, 2004, 27 (02) :547-552
[3]   The adipocyte-secreted protein Acrp30 enhances hepatic insulin action [J].
Berg, AH ;
Combs, TP ;
Du, XL ;
Brownlee, M ;
Scherer, PE .
NATURE MEDICINE, 2001, 7 (08) :947-953
[4]   Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex [J].
Cnop, M ;
Havel, PJ ;
Utzschneider, KM ;
Carr, DB ;
Sinha, MK ;
Boyko, EJ ;
Retzlaff, BM ;
Knopp, RH ;
Brunzell, JD ;
Kahn, SE .
DIABETOLOGIA, 2003, 46 (04) :459-469
[5]   The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome [J].
Comuzzie, AG ;
Funahashi, T ;
Sonnenberg, G ;
Martin, LJ ;
Jacob, HJ ;
Black, AEK ;
Maas, D ;
Takahashi, M ;
Kihara, S ;
Tanaka, S ;
Matsuzawa, Y ;
Blangero, J ;
Cohen, D ;
Kissebah, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (09) :4321-4325
[6]  
Gavin JR, 1999, DIABETES CARE, V22, pS5
[7]   Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age [J].
Hjelmesaeth, J ;
Hartmann, A ;
Kofstad, J ;
Stenstrom, J ;
Leivestad, T ;
Egeland, T ;
Fauchald, P .
TRANSPLANTATION, 1997, 64 (07) :979-983
[8]   INCREASED ADIPOSE-TISSUE EXPRESSION OF TUMOR-NECROSIS-FACTOR-ALPHA IN HUMAN OBESITY AND INSULIN-RESISTANCE [J].
HOTAMISLIGIL, GS ;
ARNER, P ;
CARO, JF ;
ATKINSON, RL ;
SPIEGELMAN, BM .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (05) :2409-2415
[9]   Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients [J].
Hotta, K ;
Funahashi, T ;
Arita, Y ;
Takahashi, M ;
Matsuda, M ;
Okamoto, Y ;
Iwahashi, H ;
Kuriyama, H ;
Ouchi, N ;
Maeda, K ;
Nishida, M ;
Kihara, S ;
Sakai, N ;
Nakajima, T ;
Hasegawa, K ;
Muraguchi, M ;
Ohmoto, Y ;
Nakamura, T ;
Yamashita, S ;
Hanafusa, T ;
Matsuzawa, Y .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (06) :1595-1599
[10]   Diabetes mellitus after kidney transplantation in the United States [J].
Kasiske, BL ;
Snyder, JJ ;
Gilbertson, D ;
Matas, AJ .
AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (02) :178-185